Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases

Cancer

Volumn 113, Issue 3, 2008, Pages 616-627

  Rouhani, Panta ^a   Fletcher, Christopher D M ^b   Devesa, Susan S ^a   Toro, Jorge R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiosarcoma; Cutaneous soft tissue sarcoma; Dermatofibrosarcoma protuberans; Kaposi sarcoma; Leiomyosarcoma; Malignant fibrous histiocytoma

Indexed keywords

ANGIOSARCOMA; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE ASSOCIATION; HISTIOCYTOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN CANCER; SOFT TISSUE SARCOMA; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETHNIC GROUPS; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; SARCOMA; SKIN NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 49049096901     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23571     Document Type: Article

References (60)

1. Zahm SH, Tucker MA, Fraumeni JF Jr. Soft tissue sarcomas. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York, NY: Oxford University Press;1996:984-999.
2. Zahm SH, Fraumeni JF Jr. The epidemiology of soft tissue sarcoma. Semin Oncol. 1997;24:504-514.
3. Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
4. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, an analysis in the Surveillance, Epidemiology, and End Results Program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119:2922-2930.
5. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-3044.
6. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 2000;88:500-517.
7. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
8. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Cancer Surveillance Series: trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204-1210.
9. Eriksson M, Hardell L, Adami HO. Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst. 1990;82:1785-1786.
10. Eriksson M, Hardell L, Berg NO, Moller T, Axelson O. Soft-tissue sarcomas and exposure to chemical substances: a case-referent study. Br J Ind Med. 1981;38:27-33.
11. Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment for breast cancer - a Swedish population-based study. Eur J Cancer. 1998;34:2068-2075.
12. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med. 1995;5:332:312-318.
13. Weiss RA, Whitby D, Talbot S, Kellam P, Boshoff C. Human herpesvirus type 8 and Kaposi's sarcoma. J Natl Cancer Inst Monogr. 1998;23:51-54.
14. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606-611.
15. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661-671.
16. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA. 2001;98:3387-3392.
17. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 13 Registries, Limited-Use (1978-2004). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission. Available at: Available at: http://www.seer.cancer. gov. Accessed February 26, 2008.
18. Fritz A, Percy C, Jack A, Kanagaratnam S, Sobin L, Parkin DM, eds. International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
19. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 6.3.5. Available at: http://www.seer.cancer.gov/seerstat. Accessed August 14, 2007.
20. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol. 1995;141:300-304.
21. Miettinen OS, Nurminen M. Comparative analysis of 2 rates. Stat Med. 1985;4:213-226.
22. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patients and Tumor Characteristics. NIH Publication 07-6215. Bethesda, Md: National Cancer Institute, SEER Program; 2007.
23. Belal A, Kandil A, Allam A, et al. Malignant fibrous histiocytoma. Am J Clin Oncol. 2002;25:16-22.
24. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:213-228.
25. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer. 1973;31:1541-1552.
26. Dei Tos AP, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol. 1994;145:11-17.
27. Wilson-Jones E. Malignant angioendothelioma of the skin. Br J Dermatol. 1964;76:21-39.
28. Mark RJ, Poen JC, Tran LM, Fu YS, Juilliard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400-2406.
29. Morgan MB, Swann M, Somach S, Eng W, Smoller B. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874.
30. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046-1057.
31. Cooper PH. Angiosarcomas of the skin. Semin Diag Pathol. 1987;4:2-17.
32. Abbbas J, Holyoke E, Moore R, Karakousis C. The surgical treatment and outcome of soft tissue sarcoma. Arch Surg. 1981;116:765-769.
33. Antman K, Eilber F, Shiu M. Soft tissue sarcomas: current trends in diagnosis and management. Curr Probl Cancer. 1989;14:340-344.
34. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. Cancer. 1948;1:64-81.
35. Rossi S, Fletcher CDM. Angiosarcoma arising in hemangioma/vascular malformation: report of 4 cases and review of the literature. Am J Surg Pathol. 2002;26:1319-1329.
36. Bessis D, Sotto A, Roubert P, et al. Endothelin-secreting angiosarcoma occurring at the site of an arteriovenous fistula for haemodialysis in a renal transplant recipient. Br J Dermatol. 1998;138:361-363.
37. Jennings TA, Peterson L, Axiotis CA, et al. Angiosarcoma associated with foreign body material. A report of 3 cases. Cancer. 1988;62:2436-2444.
38. Leake J, Sheehan MP, Rampling D, et al. Angiosarcoma complicating xeroderma pigmentosum. Histopathology. 1992;21:179-181.
39. Dunkel IJ, Gerald WL, Rosenfield NS, et al. Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience. Med Pediatr Oncol. 1998;30:59-62.
40. Marchai C, Weber B, de Lafontan B, et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive cancer centers. Int J Radiat Oncol Biol Phys. 1999;44:113-119.
41. Stokkel MP, Peterse HL. Angiosarcoma of the breast after lumpectomy and radiation for adenocarcinoma. Cancer. 1992;69:2965-2968.
42. Brenn T, CDM Fletcher. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29:983-996.
43. Benson JR, Osborne MP. Breast conservation therapy over the past 15-20 years [letter]. Breast Cancer Res Treat. 1999;55:293.
44. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
45. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
46. Pass H, Vicini FA, Kestin LL, et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer. 2004;101:713-720.
47. Brenn T, Fletcher CDM. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006;48:106-114.
48. Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJ. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela. Breast Cancer Res Treat. 1998;47:101-109.
49. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28:781-788.
50. Mendenhall WM, Zlotecki RA, Scarborough MT. Dermatofibrosarcoma protuberans. Cancer. 2004;101:2503-2508.
51. Monnier D, Vidal C, Martin T, et al. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol. 2006;20:1237-1242.
52. Criscione VD, Weinstock MA. Descriptive epidemiology of DFSP in the US, 1973 to 2002. J Am Acad Dermatol. 2007;56:968-973.
53. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140:1-12.
54. Pedeutour F, Simon MP, Minoletti F, et al. Translocation t(17;22)(q22;q13) in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996;72:171-174.
55. Zaki A, Mettlin C. Soft tissue sarcomas in whites and blacks living in the United States of America. J Surg Oncol. 1992;50:130-133.
56. Steven CB, Randall KR. Leiomyosarcoma of the skin-treatment of 34 cases. Dermatol Surg. 1996;22:631-635.
57. Polednak AP. Incidence of soft-tissue cancers in blacks and whites in New York state. Int J Cancer. 1986;38:21-26.
58. Biggar RJ. AID. S-related cancers in the era of highly active antiretrovirval therapy. Oncology (Huntingt). 2001;15:439-448.
59. Ries LAG, Melbert D, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2004. Bethesda, Md: National Cancer Institute; 2006. Available at: http://seer.cancer.gov/csr/1975_2004/based on the November 2006 SEER data submission, posted to the SEER website, 2007. Accessed February 26, 2008.
60. Rohrmus B, Thoma-Greber EM, Bogner JR, Rocken M. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet. 2000;356:2160.